Potent GH20 N-Acetyl-β-d-hexosaminidase Inhibitors: N-Substituted 3-acetamido-4-amino-5-hydroxymethyl-cyclopentanediols-Reference-Cited by-同舟云学术

Potent GH20 N-Acetyl-β-d-hexosaminidase Inhibitors: N-Substituted 3-acetamido-4-amino-5-hydroxymethyl-cyclopentanediols

Published:2018-03-20 Issue:3 Volume:23 Page:708
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

Weber Patrick,Nasseri Seyed,Pabst Bettina,Torvisco Ana,Müller Philipp,Paschke Eduard,Tschernutter Marion,Windischhofer Werner,Withers Stephen,Wrodnigg Tanja,Stütz Arnold

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/23/3/708/pdf

Reference28 articles.

1. The GM2 activator protein, its roles as a co-factor in GM2 hydrolysis and as a general glycolipid transport protein

2. Purification and characterization of an O-GlcNAc selective N-acetyl-β-d-glucosaminidase from rat spleen cytosol;Dong;J. Biol. Chem.,1994

3. The recently identified hexosaminidase D enzyme substantially contributes to the elevated hexosaminidase activity in rheumatoid arthritis

4. Crystallographic Evidence for Substrate-assisted Catalysis in a Bacterial β-Hexosaminidase

5. β-N-Acetylhexosaminidase: What's in a name…?

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N‐Methyl‐N‐Alkylaminocyclopentanes: Powerful and Selective β‐d‐Glucocerebrosidase Inhibitors;Helvetica Chimica Acta;2024-02-29

2. Highly functionalized diaminocyclopentanes: A new route to potent and selective inhibitors of human O-GlcNAcase;Bioorganic Chemistry;2023-11

3. Glycosidase-targeting small molecules for biological and therapeutic applications;Chemical Society Reviews;2023

4. Discovery of human hexosaminidase inhibitors by in situ screening of a library of mono- and divalent pyrrolidine iminosugars;Bioorganic Chemistry;2022-03

5. Diaminocyclopentane-derived O-GlcNAcase inhibitors for combating tau hyperphosphorylation in Alzheimer's disease;Chemical Communications;2022